A placebo-controlled, double-blind trial of the selective...

Alzheimer's & Dementia 2005 Vol. 1; Iss. 1-supp-S

A placebo-controlled, double-blind trial of the selective AB-42 lowering agent, flurizan (MPC-7869, (R)-flurbiprofen) in patients with mild to moderate Alzheimer’s disease

Gordon K. Wilcock, Sandra Black, Judy Haworth, Mark Laughlin, Suzanne Hendrix, Mary-Helen Binger, Kenton Zavitz, Edward Swabb, Adrian Hobden
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
1
Year:
2005
Language:
english
DOI:
10.1016/j.jalz.2005.06.330
File:
PDF, 49 KB
english, 2005
Conversion to is in progress
Conversion to is failed